Synthesis, acute toxicity and anti-inflammatory effect of bornyl salicylate, a salicylic acid derivative

References

• Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010, 140, 771–776.
   PubMed Web of Science ®Google Scholar
• Majno, G. The Healing Hand - Man and wound in the ancient world. Cambridge: MA: Harvard University Press; 1975.
   Google Scholar
• Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140, 871–882.
   PubMed Web of Science ®Google Scholar
• Vane J.R., Botting R.M. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998, 104, 2S–8S; discussion 21S.
   PubMed Web of Science ®Google Scholar
• Burian M., Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther 2005, 107, 139–154.
   PubMed Web of Science ®Google Scholar
• Morrow J.D., Roberts II L.J. Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor.. In: Brunton LL, Lazo JS, Parker KL. ed. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 12e. New York: McGraw – Hill, 2010: 911–936.
   Google Scholar
• Amann R., Peskar B.A. Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol 2002, 447, 1–9.
   PubMed Web of Science ®Google Scholar
• Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 1996, 274, 1383–1385.
   PubMed Web of Science ®Google Scholar
• Frantz B., O’Neill E.A. The effect of sodium salicylate and aspirin on NF-kappa B. Science 1995, 270, 2017–2019.
   PubMed Web of Science ®Google Scholar
• Kopp E., Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994, 265, 956–959.
   PubMed Web of Science ®Google Scholar
• Pillinger M.H., Capodici C., Rosenthal P., Kheterpal N., Hanft S., Philips M.R., Weissmann G. Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci USA 1998, 95, 14540–14545.
   PubMed Web of Science ®Google Scholar
• Wermuth C.G. Selective optimization of side activities: another way for drug discovery. J Med Chem 2004, 47, 1303–1314.
   PubMed Web of Science ®Google Scholar
• Passos C.S., Arbo M.D., Rates S.M.K., Poser G.L.V. Terpenoides com atividade sobre o Sistema Nervoso Central (SNC). Rev Bras Farmacogn 2009; 19:140–149.
   Google Scholar
• Lewis, R.J. Synonym Cross-Index. Hazardous Chemicals Desk Reference: John Wiley & Sons, Inc.; 2008. p. 1487–1945.
   Google Scholar
• Hattori A. [Camphor in the Edo era - camphor and borneol for medicines]. Yakushigaku Zasshi 2000, 35, 49–54.
   PubMedGoogle Scholar
• Hattori A. [Historical study of a moth repellent, “Fujisawa Camphor” (2) manufacture of borneol]. Yakushigaku Zasshi 2001, 36, 108–112.
   PubMedGoogle Scholar
• Stockman R. The Physiological Action of Borneol. A Contribution to the Pharmacology of the Camphor Group. J Physiol (Lond) 1888, 9, 65–91.
   Google Scholar
• Liu R., Zhang L., Lan X., Li L., Zhang T.T., Sun J.H., Du G.H. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor KappaB signaling pathway. Neuroscience 2011, 176, 408–419.
   PubMed Web of Science ®Google Scholar
• Chen X.H., Lin Z.Z., Liu A.M., Ye J.T., Luo Y., Luo Y.Y., Mao X.X., Liu P.Q., Pi R.B. The orally combined neuroprotective effects of sodium ferulate and borneol against transient global ischaemia in C57 BL/6J mice. J Pharm Pharmacol 2010, 62, 915–923.
   PubMed Web of Science ®Google Scholar
• Horváthová E., Slamenová D., Marsálková L., Sramková M., Wsólová L. Effects of borneol on the level of DNA damage induced in primary rat hepatocytes and testicular cells by hydrogen peroxide. Food Chem Toxicol 2009, 47, 1318–1323.
   PubMed Web of Science ®Google Scholar
• Silva-Filho J.C., Oliveira N.N., Arcanjo D.D., Quintans-Junior L.J., Cavalcanti S.C., Santos M.R., et al. Investigation of Mechanisms Involved in (-)-Borneol-Induced Vasorelaxant Response on Rat Thoracic Aorta. Basic Clin Pharmacol Toxicol. 2012:110:171–177.
   PubMed Web of Science ®Google Scholar
• Food and drugs analysis. Analyst 1914; 39(465).
   Google Scholar
• Thomas M.R. Salicylic Acid and Related Compounds. [Online] In: Kirk-Othmer Encyclopedia of Chemical Technology: John Wiley & Sons, Inc.; 2006. Available at: http://dx.doi.org/10.1002/0471238961.1901120920081513.a01.pub2
   Google Scholar
• Almeida R.N., Falcão A.C.G.M., Diniz R.S.T., Quintans-Júnior L.J., Polari R.M., Barbosa-Filho J.M., Agra M.F., Duarte J.C., Ferreira C.D., Antoniolli A.R., Araújo C.C. Metodologia para avaliação de plantas com atividade no sistema nervoso central e alguns dados experimentais. Rev Bras Farm 80, 1999:72–76.
   Google Scholar
• de Vasconcelos D.I., Leite J.A., Carneiro L.T., Piuvezam M.R., de Lima M.R., de Morais L.C., Rumjanek V.M., Rodrigues-Mascarenhas S. Anti-inflammatory and antinociceptive activity of ouabain in mice. Mediators Inflamm 2011, 2011, 912925.
   PubMed Web of Science ®Google Scholar
• Marinho M.G.V., Brito A.G., Carvalho K.A., Bezerra-Santos C.R., Andrade L.H.C., Barbosa-Filho J.M., et al. Amburana cearensis e cumarina imunomodulam os níveis de anticorpos antígeno-específico em camundongos BALB/c sensibilizados com ovalbumina. Lat Am J Pharm 2004; 23:5.
   Google Scholar
• Doherty N.S., Poubelle P., Borgeat P., Beaver T.H., Westrich G.L., Schrader N.L. Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2. Prostaglandins 1985, 30, 769–789.
   PubMed Web of Science ®Google Scholar
• Kolaczkowska E., Koziol A., Plytycz B., Arnold B. Inflammatory macrophages, and not only neutrophils, die by apoptosis during acute peritonitis. Immunobiology 2010, 215, 492–504.
   PubMed Web of Science ®Google Scholar
• Costa H.F., Bezerra-Santos C.R., Barbosa Filho J.M., Martins M.A., Piuvezam M.R. Warifteine, a bisbenzylisoquinoline alkaloid, decreases immediate allergic and thermal hyperalgesic reactions in sensitized animals. Int Immunopharmacol 2008, 8, 519–525.
   PubMed Web of Science ®Google Scholar
• Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982, 126, 131–138.
   PubMed Web of Science ®Google Scholar
• Tim M. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55–63.
   PubMed Web of Science ®Google Scholar
• Lai L.H., Chan F.K. Nonsteroid anti-inflammatory drug-induced gastroduodenal injury. Curr Opin Gastroenterol 2009, 25, 544–548.
   PubMed Web of Science ®Google Scholar
• Anderson G.D. Gender differences in pharmacological response. Int Rev Neurobiol 2008, 83, 1–10.
   PubMed Web of Science ®Google Scholar
• Winter C.A., Risley E.A., Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 1962, 111, 544–547.
   PubMed Web of Science ®Google Scholar
• Levy L. Carrageenan paw edema in the mouse. Life Sci 1969, 8, 601–606.
   PubMed Web of Science ®Google Scholar
• Vaz Z.R., Filho V.C., Yunes R.A., Calixto J.B. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice. J Pharmacol Exp Ther 1996, 278, 304–312.
   PubMed Web of Science ®Google Scholar
• Medeiros M.V., Binhara I.M., Moreno Júnior H., Zatz R., De Nucci G., Antunes E. Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats. Eur J Pharmacol 1995, 285, 109–114.
   PubMed Web of Science ®Google Scholar
• Handy R.L., Moore P.K. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br J Pharmacol 1998, 123, 1119–1126.
   PubMed Web of Science ®Google Scholar
• Damas J., Remacle-Volon G. Influence of a long-acting bradykinin antagonist, Hoe 140, on some acute inflammatory reactions in the rat. Eur J Pharmacol 1992, 211, 81–86.
   PubMed Web of Science ®Google Scholar
• Posadas I., Bucci M., Roviezzo F., Rossi A., Parente L., Sautebin L., Cirino G. Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol 2004, 142, 331–338.
   PubMed Web of Science ®Google Scholar
• Falcão E.P., de Melo S.J., Srivastava R.M., Catanho M.T., Do Nascimento S.C. Synthesis and antiinflammatory activity of 4-amino-2-aryl-5-cyano-6-{3- and 4-(N-phthalimidophenyl)} pyrimidines. Eur J Med Chem 2006, 41, 276–282.
   PubMed Web of Science ®Google Scholar
• Rinaldi S., Silva D.O., Bello F., Alviano C.S., Alviano D.S., Matheus M.E., Fernandes P.D. Characterization of the antinociceptive and anti-inflammatory activities from Cocos nucifera L. (Palmae). J Ethnopharmacol 2009, 122, 541–546.
   PubMed Web of Science ®Google Scholar
• Claudino R.F., Kassuya C.A., Ferreira J., Calixto J.B. Pharmacological and molecular characterization of the mechanisms involved in prostaglandin E2-induced mouse paw edema. J Pharmacol Exp Ther 2006, 318, 611–618.
   PubMed Web of Science ®Google Scholar
• Ushikubi F., Segi E., Sugimoto Y., Murata T., Matsuoka T., Kobayashi T., Hizaki H., Tuboi K., Katsuyama M., Ichikawa A., Tanaka T., Yoshida N., Narumiya S. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 1998, 395, 281–284.
   PubMed Web of Science ®Google Scholar
• DiPasquale G., Rassaert C., Richter R., Welaj P., Tripp L. Influence of prostaglandins (Pg) E2 and F2 on the inflammatory process. Prostaglandins 1973, 3, 741–757.
   PubMed Web of Science ®Google Scholar
• Maurer M., Bader M., Bas M., Bossi F., Cicardi M., Cugno M., Howarth P., Kaplan A., Kojda G., Leeb-Lundberg F., Lötvall J., Magerl M. New topics in bradykinin research. Allergy 2011, 66, 1397–1406.
   PubMed Web of Science ®Google Scholar
• Kaplan A.P., Joseph K., Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 2002, 109, 195–209.
   PubMed Web of Science ®Google Scholar
• Campos M.M., Calixto J.B. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema. Br J Pharmacol 1995, 114, 1005–1013.
   PubMed Web of Science ®Google Scholar
• Buritova J., Chapman V., Honoré P., Besson J.M. The contribution of peripheral bradykinin B2 receptors to carrageenan-evoked oedema and spinal c-Fos expression in rats. Eur J Pharmacol 1997, 320, 73–80.
   PubMed Web of Science ®Google Scholar
• Gardes J., Michineau S., Pizard A., Alhenc-Gelas F., Rajerison R.M. Aspirin inhibits human bradykinin B2 receptor ligand binding function. Biochem Pharmacol 2008, 75, 1807–1816.
   PubMed Web of Science ®Google Scholar
• Jutel M., Akdis M., Akdis C.A. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 2009, 39, 1786–1800.
   PubMed Web of Science ®Google Scholar
• Skidgel R.A., Erdös E.G.. Histamine, Bradykinin, and Their Antagonists.. In: Brunton LL, Lazo JS, Parker KL, ed. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 12e. New York: McGraw – Hill, 2010:937–958.
   Google Scholar
• Whittle B.A. The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic alalgesics. Br J Pharmacol Chemother 1964, 22, 246–253.
   PubMed Web of Science ®Google Scholar
• Deraedt R., Jouquey S., Delevallée F., Flahaut M. Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 1980, 61, 17–24.
   PubMed Web of Science ®Google Scholar
• Collier H.O., Dinneen L.C., Johnson C.A., Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 1968, 32, 295–310.
   PubMed Web of Science ®Google Scholar
• Leite D.F., Echevarria-Lima J., Ferreira S.C., Calixto J.B., Rumjanek V.M. ABCC transporter inhibition reduces zymosan-induced peritonitis. J Leukoc Biol 2007, 82, 630–637.
   PubMed Web of Science ®Google Scholar
• El Alwani M., Wu B.X., Obeid L.M., Hannun Y.A. Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther 2006, 112, 171–183.
   PubMed Web of Science ®Google Scholar
• Zheng Z., Li H., Zhang Z., Meng J., Mao D., Bai B., Lu B., Mao P., Hu Q., Wang H. Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation. J Immunol 2011, 187, 2202–2212.
   PubMed Web of Science ®Google Scholar
• Sun S.C. Non-canonical NF-κB signaling pathway. Cell Res 2011, 21, 71–85.
   PubMed Web of Science ®Google Scholar
• Juhás S., Cikos S., Czikková S., Veselá J., Il’ková G., Hájek T., Domaracká K., Domaracký M., Bujnáková D., Rehák P., Koppel J. Effects of borneol and thymoquinone on TNBS-induced colitis in mice. Folia Biol (Praha) 2008, 54, 1–7.
   PubMed Web of Science ®Google Scholar
• Oswald I.P., Wynn T.A., Sher A., James S.L. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci USA 1992, 89, 8676–8680.
   PubMed Web of Science ®Google Scholar
• Hackstein H., Morelli A.E., Larregina A.T., Ganster R.W., Papworth G.D., Logar A.J., Watkins S.C., Falo L.D., Thomson A.W. Aspirin inhibits in vitromaturation and in vivoimmunostimulatory function of murine myeloid dendritic cells. J Immunol 2001, 166, 7053–7062.
   PubMed Web of Science ®Google Scholar
• Bufan B., Mojsilovic S., Vucicevic D., Vucevic D., Vasilijic S., Balint B., Colic M. Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro. Int Immunopharmacol 2009, 9, 910–917.
   PubMed Web of Science ®Google Scholar
• Bergman M., Djaldetti M., Salman H., Bessler H. Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells? Inflammation 2011, 34, 22–28.
   PubMed Web of Science ®Google Scholar
• Lin C.F., Tsai C.C., Huang W.C., Wang C.Y., Tseng H.C., Wang Y., Kai J.I., Wang S.W., Cheng Y.L. IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10. J Cell Biochem 2008, 105, 746–755.
   PubMed Web of Science ®Google Scholar
• Kröncke K.D., Fehsel K., Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection–how, why, when, and where? Nitric Oxide 1997, 1, 107–120.
   PubMed Web of Science ®Google Scholar
• Drapier J.C., Hibbs J.B. Jr. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 1988, 140, 2829–2838.
   PubMed Web of Science ®Google Scholar
• Aller M.A., Arias J.L., Sánchez-Patán F., Arias J. The inflammatory response: an efficient way of life. Med Sci Monit 2006, 12, RA225–RA234.
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz J., Grabowska A., Chain B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 1995, 25, 947–951.
   PubMed Web of Science ®Google Scholar
• Mollace V., Muscoli C., Masini E., Cuzzocrea S., Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 2005, 57, 217–252.
   PubMed Web of Science ®Google Scholar
• Hibbs J.B. Jr, Taintor R.R., Vavrin Z. Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun 1984, 123, 716–723.
   PubMed Web of Science ®Google Scholar